FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Large Molecule Development
FUJIFILM Diosynth Biotechnologies is a CDMO Partner for Life offering end-to-end development and manufacturing solutions. They combine 30 years’ experience and technical leadership in cell culture, microbial fermentation and advanced therapies with world class cGMP facilities and superior program management to advance tomorrow’s medicines.
Currently, FDB has over 4000 employees in 6 global locations. Here, speaker Rasmus Petersen, Associate Director kojoX and Technology Development, presents a high-level overview of FDB’s capabilities, discusses their global facilities network, and provides capacity updates for BIOLOGICS products.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.